-
Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright
ソース: Buzz FX / 23 1 2025 08:21:16 America/New_York
Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright Written by MarketBeat January 23, 2025 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rating reaffirmed b
Read more...